arrow
S

Seok Kyu Oh

keimyung university
H指数:25
被引数:2,811

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and Safety of CENTUMTM, an Everolimus-Eluting Stent, in Patients With Coronary Artery Disease: A Prospective Multi-Center Observational Study

CENTUMTM(依维莫司洗脱支架)在冠状动脉疾病患者中的有效性与安全性:一项前瞻性多中心观察性研究

2025-12-011
OA
Renal function-dependent risk of early invasive strategy in patients with non-ST-segment elevation myocardial infarction: insight from KAMIR-NIH and KRAMI-RCC
2025-11-010
PRE
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION–STEMI): a multicentre, non-inferiority, open-label, randomised trial

在ST段抬高型心肌梗死合并多支血管病变患者首次入院期间,即刻与分阶段完全血运重建的比较(OPTION–STEMI):一项多中心、非劣效性、开放标签、随机试验

2025-08-310
PRE
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial
2024-07-010
OAAI
Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model
2023-11-163
OA
Early Invasive Strategy Based on the Time of Symptom Onset of Non-ST-Segment Elevation Myocardial Infarction
2023-01-015
OAAI
Durable polymer versus biodegradable polymer drug-eluting stents in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: a post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial
2022-12-011
OA
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS Trial
2022-04-0112
OA
Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70 mg/dL vs. <55 mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health

韩国急性心肌梗死患者的最佳低密度脂蛋白胆固醇目标水平 (<70 mg/dL与 <55 mg/dL): 基于韩国急性心肌梗死注册-国立卫生研究院

2022-03-014
PRE
P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
HEART
IF4.4
2021-03-235
PRE